1. Home
  2. SCPH vs OPOF Comparison

SCPH vs OPOF Comparison

Compare SCPH & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • OPOF
  • Stock Information
  • Founded
  • SCPH 2013
  • OPOF 1922
  • Country
  • SCPH United States
  • OPOF United States
  • Employees
  • SCPH N/A
  • OPOF N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • OPOF Major Banks
  • Sector
  • SCPH Health Care
  • OPOF Finance
  • Exchange
  • SCPH Nasdaq
  • OPOF Nasdaq
  • Market Cap
  • SCPH 173.6M
  • OPOF 207.2M
  • IPO Year
  • SCPH 2017
  • OPOF N/A
  • Fundamental
  • Price
  • SCPH $3.64
  • OPOF $39.55
  • Analyst Decision
  • SCPH Strong Buy
  • OPOF
  • Analyst Count
  • SCPH 3
  • OPOF 0
  • Target Price
  • SCPH $14.00
  • OPOF N/A
  • AVG Volume (30 Days)
  • SCPH 423.8K
  • OPOF 9.0K
  • Earning Date
  • SCPH 05-14-2025
  • OPOF 07-24-2025
  • Dividend Yield
  • SCPH N/A
  • OPOF 1.42%
  • EPS Growth
  • SCPH N/A
  • OPOF 55.28
  • EPS
  • SCPH N/A
  • OPOF 1.96
  • Revenue
  • SCPH $41,982,000.00
  • OPOF $61,370,000.00
  • Revenue This Year
  • SCPH $109.32
  • OPOF N/A
  • Revenue Next Year
  • SCPH $76.95
  • OPOF N/A
  • P/E Ratio
  • SCPH N/A
  • OPOF $20.19
  • Revenue Growth
  • SCPH 138.10
  • OPOF 5.28
  • 52 Week Low
  • SCPH $1.94
  • OPOF $13.70
  • 52 Week High
  • SCPH $5.65
  • OPOF $40.88
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 66.63
  • OPOF 56.41
  • Support Level
  • SCPH $3.23
  • OPOF $38.83
  • Resistance Level
  • SCPH $3.74
  • OPOF $40.30
  • Average True Range (ATR)
  • SCPH 0.31
  • OPOF 0.68
  • MACD
  • SCPH 0.08
  • OPOF -0.24
  • Stochastic Oscillator
  • SCPH 93.81
  • OPOF 35.12

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About OPOF Old Point Financial Corporation

Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.

Share on Social Networks: